|Venture Round, 3/10 |
Minority Angel Investor Network
Life Sciences Greenhouse of Pennsylvania
The Trisiras Group
Immunomic Therapeutics, Inc., a development stage biotechnology company, develops lysosomal associated membrane protein based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.